Erbe, A. K. (2018). Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationErbe, A. K. Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationErbe, A. K. Neuroblastoma Patients' KIR and KIR-Ligand Genotypes Influence Clinical Outcome for Dinutuximab-based Immunotherapy: A Report from the Children's Oncology Group. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.